Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xinnovation Therapeutics
China
- Ownership
- Private
- Development stage
- Other
01
Overview
Xinnovation Therapeutics has entered into a licensing and manufacturing partnership for ABV-1504 and ABV-1505, both botanical drugs for CNS indications, focusing on the Chinese market; clinical trial data and commercial results not disclosed[1][4].
- Therapeutic areas
- NeurologyPsychiatry
- Modalities
- Botanical drugSmall molecule
- Industry
- Biotech
02
Partnerships
ABVC BioPharma (ABVC) (licensing and development deal for 2 CNS drugs)collaborations with other unnamed Chinese pharmaceutical companies for raw material cultivation and manufacturing
Beyond the preview
Go deeper on Xinnovation Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xinnovation Therapeutics.